These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38457230)

  • 1. Harnessing natural killer cells to target HIV-1 persistence.
    Joshi VR; Altfeld M
    Curr Opin HIV AIDS; 2024 May; 19(3):141-149. PubMed ID: 38457230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
    Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
    J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
    J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency.
    Covino DA; Desimio MG; Doria M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent
    Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological strategies to target HIV persistence.
    Martrus G; Altfeld M
    Curr Opin HIV AIDS; 2016 Jul; 11(4):402-8. PubMed ID: 27054281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
    Kwaa AKR; Talana CAG; Blankson JN
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV.
    Ghofrani J; Bowen A; Chen J; Balakrishnan PB; Powell AB; Cherukula K; Cruz CRY; Jones RB; Lynch RM; Sweeney EE; Fernandes R
    Int J Nanomedicine; 2023; 18():4055-4066. PubMed ID: 37520301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
    Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
    J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors.
    Furtado Milão J; Love L; Gourgi G; Derhaschnig L; Svensson JP; Sönnerborg A; van Domselaar R
    Front Immunol; 2022; 13():1067767. PubMed ID: 36561752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Utility of Natural Killer Cells for Eliminating Cells Harboring Reactivated Latent HIV-1 Following the Removal of CD8
    Khoury G; Kulpa DA; Parsons MS
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor SAHA simultaneously reactivates HIV-1 from latency and up-regulates NKG2D ligands sensitizing for natural killer cell cytotoxicity.
    Desimio MG; Giuliani E; Doria M
    Virology; 2017 Oct; 510():9-21. PubMed ID: 28689087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.
    Webb GM; Molden J; Busman-Sahay K; Abdulhaqq S; Wu HL; Weber WC; Bateman KB; Reed JS; Northrup M; Maier N; Tanaka S; Gao L; Davey B; Carpenter BL; Axthelm MK; Stanton JJ; Smedley J; Greene JM; Safrit JT; Estes JD; Skinner PJ; Sacha JB
    PLoS Pathog; 2020 Mar; 16(3):e1008339. PubMed ID: 32163523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir.
    Covino DA; Desimio MG; Doria M
    Sci Rep; 2022 Nov; 12(1):18567. PubMed ID: 36329160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of latency reversal in HIV cure strategies.
    Tanaka K; Kim Y; Roche M; Lewin SR
    J Med Primatol; 2022 Oct; 51(5):278-283. PubMed ID: 36029233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure.
    Schober R; Brandus B; Laeremans T; Iserentant G; Rolin C; Dessilly G; Zimmer J; Moutschen M; Aerts JL; Dervillez X; Seguin-Devaux C
    J Transl Med; 2023 Nov; 21(1):791. PubMed ID: 37936122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic approaches to HIV cure and remission.
    Lee MJ; Fidler S; Frater J
    Curr Opin Infect Dis; 2022 Feb; 35(1):31-41. PubMed ID: 34873077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.